Aging is a risk factor for many human pathologies and is characterized by extensive metabolic changes. Using targeted high-throughput metabolite profiling in Drosophila melanogaster at different ages, we demonstrate that methionine metabolism changes strikingly during aging. Methionine generates the methyl donor S-adenosylmethionine (SAM), which is converted via methylation to S-adenosyl-homocysteine (SAH), which accumulates during aging. A targeted RNAi screen against methionine pathway components revealed significant life span extension in response to down-regulation of two noncanonical Drosophila homologs of the SAH hydrolase Ahcy (S-adenosyl-L-homocysteine hydrolase [SAHH[), CG9977/dAhcyL1 and Ahcy89E/CG8956/dAhcyL2, which act as dominant-negative regulators of canonical AHCY. Importantly, tissue-specific down-regulation of dAhcyL1/L2 in the brain and intestine extends health and life span. Furthermore, metabolomic analysis of dAhcyL1-deficient flies revealed its effect on age-dependent metabolic reprogramming and H3K4 methylation. Altogether, reprogramming of methionine metabolism in young flies and suppression of age-dependent SAH accumulation lead to increased life span. These studies highlight the role of noncanonical Ahcy enzymes as determinants of healthy aging and longevity.
Aging is the primary risk factor for many major human pathologies, including cancer, diabetes, cardiovascular disorders, and neurodegenerative diseases (Lopez-Otin et al. 2013) . Previous studies of the transcriptional changes that occur during Drosophila aging have revealed that genes encoding members of metabolic pathways are among the most affected (Landis et al. 2004; Lai et al. 2007 ). In addition, analyses of changes associated with dietary restriction (DR) that slows down the aging process have also demonstrated dramatic changes in the expression of different metabolic genes (Pletcher et al. 2002) . Similarly, studies in worms (Fuchs et al. 2010 ), mice (Tomas-Loba et al. 2013) , and humans (Yu et al. 2012) have documented changes in the metabolome during the aging process. Recently, untargeted metabolomics analysis in flies (Hoffman et al. 2014) has suggested that DR might reverse age-dependent metabolic reprogramming at the tissue (Laye et al. 2015) and whole-organism (Avanesov et al. 2014) levels. Despite these studies, the mechanisms underlying age-dependent metabolic reprogramming, the nature of the metabolites that change with time, and their effect on life span are still poorly characterized.
A number of alterations in metabolic pathway activities are known to extend life span in flies and other organisms. Among them, perturbation of components of the mitochondrial respiratory complexes I, III, IV, and V (Copeland et al. 2009; Owusu-Ansah et al. 2013) ; increased mitochondrial uncoupling via expression of human UCP2 (Fridell et al. 2005) ; heterozygous mutations of AMP biosynthetic enzymes (Stenesen et al. 2013) ; reduced levels of Enigma, the enzyme responsible for β-oxidation of fatty acids (Mourikis et al. 2006) ; and reduced levels of Indy, which functions as a cation-independent electroneutral transporter for a variety of tricarboxylic acid cycle intermediates (Rogina et al. 2000) extend life span in Drosophila. In addition, key longevity regulators such as insulin receptor substrate (IRS)/chico and JNK are known to reprogram whole-body metabolism, but it is unknown whether this reprogramming is responsible for life span extension (Clancy et al. 2001; Wang et al. 2003) .
Another level of complexity between metabolism and aging arises from the observation that different tissues have different metabolic requirements and that alterations of different metabolic components or upstream regulators of metabolism in one tissue can affect aging of other tissues and life span (Finkel 2015) . For example, muscle-specific FOXO/4E-BP signaling retards muscle aging in Drosophila in a cell-autonomous manner and nonautonomously extends life span and preserves proteostasis in other aging tissues such as the brain, the retina, and adipose tissue (Demontis and Perrimon 2010) . Similarly, overexpression of AMPK in the adult Drosophila nervous system nonautonomously maintains proteostasis during muscle aging and extends organismal life span (Ulgherait et al. 2014 ). In addition, muscle-specific mitochondrial injury promotes organismal life span via activation of mtUPR and increased production of ImpL2, an insulin growth factorbinding protein (IGFBP)-like protein (Owusu-Ansah et al. 2013) . Moreover, muscle-specific expression of the transcription factor Mnt extends life span by reducing ribosome biogenesis and promoting the expression of the myokine Myoglianin (Demontis et al. 2014) .
To expand our knowledge of the regulation of life span by metabolism, we performed high-throughput metabolite profiling of Drosophila melanogaster to identify changes that may correlate with aging. Strikingly, methionine metabolism emerged as one of the most regulated metabolic pathways with age. To test the role of the methionine pathway in life span determination, we performed a targeted RNAi screen against most of the methionine pathway components and related enzymes. Unexpectedly, ubiquitous down-regulation of two Drosophila homologs of S-adenosyl-homocysteine (SAH) hydrolase-like proteins, CG9977/dAhcyL1 (S-adenosyl-L-homocysteine hydrolase [SAHH] ) and CG8956/Ahcy89E/dAhcyL2, significantly extended life span. Moreover, brain-specific down-regulation of dAhcyL1 and intestine-specific down-regulation of both dAhcyL1 and dAhcyL2 increased life span. Importantly, down-regulation of dAhcyL1 extended not only life span but also health span. Finally, suppression of dAhcyL1 activities decreased the level of SAH, as determined by tandem mass spectrometry (MS/ MS), and suppressed H3K4 trimethylation (H3K4me3), thus phenocopying methionine starvation. Altogether, our data demonstrate that dAhcyL1 and dAhcyL2 encode new key regulators of age-dependent metabolic reprogramming and control both health span and life span.
Results

Age-dependent reprogramming of methionine metabolism
To investigate the impact of age on the metabolism of adult flies, we performed high-throughput steady-state metabolite profiling using targeted liquid chromatography-MS/MS (LC-MS/MS) (Yuan et al. 2012 ) of two common Drosophila strains (yw and OregonR [OreR]) at 1, 4, and 7 wk of age (Fig. 1A) . We identified 107 and 112 metabolites that were significantly changed between 1 and 7 wk in OreR males and yw males, respectively, with 51 changed in both strains (Fig. 1B,C) . A similar analysis in females identified 121 and 113 metabolites that were significantly affected, with 54 in common (Supplemental Fig. 1A,B) . Interestingly, only 21 regulated metabolites were shared between males and females, indicating that sex has a strong effect on age-specific variations of the metabolome (Supplemental Fig. 2E and List 1). Strikingly, among the 21 metabolites that similarly changed with age in both males and females of different fly strains, five belong to the methionine pathway (betaine, cystathionine, spermidine, methionine sulfoxide, and glutathione) (Fig. 1D,E) . Next, we focused our analysis on males, as metabolic changes in females could be affected by egg production, which decreases with age. Principal component analysis (PCA) of the measured metabolites clearly distinguished flies of different ages (1, 4, and 7 wk of age) for both the OreR and yw strains (Supplemental Fig. 2F ). Interestingly, the changes in metabolite concentrations were bidirectional in that about half of them were increased with age, whereas others were decreased, suggesting that the metabolic changes observed during aging did not reflect simply a decrease in metabolic activity but rather an age-dependent metabolic reprogramming. Although we measured steady-state metabolite levels (Yuan et al. 2012) , mapping the metabolites onto the methionine metabolism pathway (Fig. 1F) suggested a decreased activity of the methionine cycle with age. In the methionine cycle, S-adenosylmethionine (SAM) is used for methylation reactions and generates SAH, which is further hydrolyzed by AHCY into homocysteine and adenosine (Brosnan and Brosnan 2006) . Homocysteine is a key branch point intermediate in the methionine cycle, as it can be remethylated back to methionine using betaine or 5-methyl-THF as methyl donors and retained in the methionine cycle. Alternatively, homocysteine can be converted into cysteine, the precursor of glutathione, via generation of cystathionine (Fig. 1F; Brosnan and Brosnan 2006) . Strikingly, the levels of methionine, cystathionine, and glutathione were decreased with age, whereas the levels of betaine as well as SAH were increased, suggesting that methionine metabolism was decreased with age. Our metabolomics results suggest that decreased activity of the methionine cycle results in a decreased demand for betaine and is associated with the suppressed clearance of SAH. Altogether, these findings suggest that whole-body methionine metabolism is reprogrammed during aging, which is accompanied by SAH accumulation.
Naturally selected long-lived flies have altered methionine metabolism
To test whether increased life span is associated with specific changes in methionine metabolism, we compared the metabolomes of long-lived flies with wild type. To prevent bias for specific signaling pathways associated with life span extension, we used flies with increased longevity that have been selected for delayed reproductive senescence. These long-lived flies were selected for over 170 generations and maintained on a generation interval of 70 d, while unselected control lines were maintained on a 2-wk generation interval (Carnes et al. 2015) . We compared the metabolic profiles of males of two different long-lived lines, O1 and O3, with a control line (B3) at 1 wk of age ( Fig. 2A) . PCA clearly distinguished control and long-lived flies when 100% of all flies were still alive (Fig. 2B) . Strikingly, we found dramatic differences between control B3 and long-lived O1 and O3 flies for many metabolites associated with methionine metabolism (betaine, spermidine, methionine, and methionine sulfoxide), including those that changed with age ( Fig.  2C,D) . However, contrary to the changes observed with age, the changes in steady-state metabolite levels in O1 and O3 flies suggested an increased flux via the methionine cycle. Specifically, the lower levels of betaine and 5-methyl-THF in O1 and O3 flies suggested increased demands for methyl donors in the methionine cycle for methionine production. In addition, O1 and O3 flies had lower levels of homocysteine, suggesting that this metabolite is more efficiently transformed back into methionine. In the methionine cycle, homocysteine can be irreversibly converted into cystathionine and cysteine and then into glutathione and taurine (major antioxidants) via the transsulfuration branch (Brosnan and Brosnan 2006) . Interestingly, long-lived O1 and O3 flies had lower levels of cystathionine and cysteine compared with B3 control flies, suggesting that the activity of the transsulfuration branch is increased in B3 flies. The increased activity of the transsulfuration branch in control B3 flies could be associated with increased demands for antioxidant molecules due to increased requirements to cope with oxidative stress and the shunting of homocysteine away from the methionine cycle. In contrast, the higher activity of the methionine cycle in long-lived O1 and O3 flies would allow better clearance of its intermediate metabolites. Consistently, the levels of SAH were significantly decreased at 4 wk of age in long-lived O1 and O3 flies compared with control B3 flies. In addition and in agreement with the potentially higher activity of the methionine cycle in O1 and O3 flies, the level of methionine was significantly higher in long-lived flies at 1 wk of age (Fig. 2C ). These results indicate that the high level of methionine itself is not associated with decreased life span and suggest that the rate of methionine processing is important for life span. Altogether, our data support the model that reprogramming of methionine metabolism in young flies and suppression of age-dependent SAH accumulation is associated with increased life span. dAhcyL1 and dAhcyL2 regulate both life span and health span Because methionine restriction extends life span in different organisms (Orentreich et al. 1993; Koziel et al. 2014; Lee et al. 2014) , multiple components of methionine metabolism change with age, and methionine levels are significantly different in short-and long-lived flies, we systematically evaluated the effect of methionine metabolism enzymes on life span using RNAi. To avoid lethality during development and differences in genetic background, we used the Actin GeneSwitch (ActinGS)- inducible Gal4/UAS expression system (Osterwalder et al. 2001; Roman et al. 2001) , by which UAS-RNAi expression is driven by Gal4 when flies are fed mifepristone (RU486). As expected, RNAi against white (w) or luciferase overexpression did not affect life span, whereas Rheb RNAi significantly extended life span (12.9% median life span increase, P < 0.0001) (Fig. 3A,B) . Rheb was used as a control, as it encodes a positive regulator of mTOR activity, and mTOR suppression has been shown to extend life span in different organisms, including Drosophila (Bjedov et al. 2010) . The methionine metabolism pathway consists of three branches (salvage, de novo, and transsulfuration pathways), and we used 53 different RNAi and overexpression lines to target 35 enzymes in all branches of methionine metabolism and adjacent pathways (Supplemental Table 1 ). As reported previously (Kabil et al. 2011) , down-regulation of cystathionine β-synthase (CBS), a rate-limiting enzyme in the transsulfuration pathway responsible for the production of glutathione and taurine, led to shortened life span (16% decrease in median life span, P < 0.0001) (Fig. 3A) . In addition, down-regulation of methionyl-tRNA synthetase/ CG15100 (which covalently links methionine with its cognate tRNA) and RNAi against the mitochondrial SAM transporter CG4743 exhibited the most dramatic life span decreases (25% and 34% decrease in median life span, respectively) (Fig. 3A) . Unexpectedly, down-regulation of two out of the three Drosophila homologs of Ubiquitous adult-onset expression of Rheb RNAi increases life span in males. P < 0.0001. (C) Ubiquitous adult-onset expression of dAhcyL1 RNAi increases life span in males. P < 0.0001 (for both 1× and 2× concentrations of RU486). (D) Ubiquitous adult-onset expression of dAhcyL1 RNAi-2 increases life span in females. P < 0.0001 (for both 1× and 2× concentrations of RU486). (E) Ubiquitous adult-onset expression of dAhcyL1 RNAi-1 (HM05009) increases life span in males. P < 0.0001. (F ) Ubiquitous adult-onset expression of dAhcyL2 RNAi-1 increases life span in males. P < 0.0001. (G) Ubiquitous adult-onset expression of dAhcyL2 RNAi-2 increases life span in males. P < 0.0001. AHCY-dAhcyL1 (dAhcyL1 RNAi-2, 9.4% median life span increase in males and 11% in females [ Fig. 3C,D] ; and dAhcyL1 RNAi-1, 12.5% median life span increase, P < 0.0001 [ Fig. 3E] ) and dAhcyL2 (dAhcyL2 RNAi-1, 21.4% median life span increase, P < 0.0001 [Fig. 3F ]; and dAhcyL2 RNAi-2, 7.8% median life span increase, P < 0.0001 [ Fig. 3G ])-significantly extended life span in adult males and females. The knockdown efficacy of dAhcyL1 (Supplemental Fig. 3A ) and dAhcyL2 (Supplemental Fig. 3B ) RNAi lines was tested using the ubiquitous Actin5c-Gal4 driver, and stronger levels of RNAi efficiency were consistent with more robust life span extension. Importantly, the level of dAhcyL1 was significantly decreased in long-lived O1 and O3 flies compared with B3 control flies at 1 wk of age, which is consistent with low levels of dAhcyL1 increasing life span (Supplemental Fig. 3C ). However, these differences are only correlative, and there are multiple changes that explain the increased life span of long-lived O1 and O3 flies. In summary, our data suggest that dAhcyL1 and dAhcyL2 are new life span regulators.
dAhcyL1 and dAhcyL2 regulate health span
To characterize how loss of dAhcyL1 and dAhcyL2 affects health span, we tested their abilities to delay age-dependent tissue functional decline as measured by maintaining climbing activity (indicative of neuromuscular function), intestine barrier, and egg laying. Normally, skeletal muscle function declines during aging in flies (Demontis et al. 2013 ). However, down-regulation of dAhcyL1 (Fig.  4A ,B) and dAhcyL2 (Fig. 4C) suppressed the age-dependent decrease of climbing activity, as determined by negative geotaxis assays. Aging is also characterized by decreased reproductive function, which, by itself, can extend life span (Sgro and Partridge 1999) . However, down-regulation of dAhcyL1 increased fecundity (Fig.  4D) , suggesting that dAhcyL1-increased life span is not due to impaired reproduction. Finally, we measured the intestinal integrity of flies fed with a nonabsorbable blue food dye (the "Smurf assay") (Rera et al. 2011) . Strikingly, down-regulation of both dAhcyL1 (Fig. 4E ) and dAhcyL2 (Fig. 4F) retarded the age-related onset of the "Smurf" phenotype, suggesting improved intestinal integrity in old flies. As expected, expression of control (w) RNAi did not affect egg production, climbing, or intestinal integrity (data not shown). An additional hallmark of extended longevity is an increased ability to withstand oxidative stress. Thus, we tested the survival of ActinGS-Gal4>dAhcyL1 RNAi-1 flies with and without RU486 added to food containing 10 mM methyl viologen dichloride hydrate (paraquat), an oxidant compound. Interestingly, we observed no difference in the survival of control and dAhcyL1 RNAi flies (Supplemental Fig. 4) , suggesting that the life span increase associated with down-regulation of dAhcyL1 is not caused by an increased ability to withstand oxidative stress. In summary, our data indicate that dAhcyL1 and dAhcyL2 encode new life span and health span regulators and that their effects are independent of oxidative stress resistance.
Down-regulation of dAhcyL1 in the brain and dAhcyL1 and dAhcyL2 in the intestine increase life span
To further dissect the role of dAhcyL1 and dAhcyL2 in life span, we tested whether specific tissues were responsible for life span extension. Expression of either dAhcyL1 RNAi-1 or dAhcyL2 RNAi-1 in the whole-body fat body of adult flies starting at 1 wk of age using the GeneSwitch driver strain (WB-FB-GS), which contains both a head fat body driver (S1-32) and a body fat body driver (S1-106) (Giannakou et al. 2007; Shen et al. 2009 ), did not affect life span in either males or females (Fig. 4G,H) . However, using the Elav GeneSwitch driver (Elav-GS), which drives nervous system-specific expression (Osterwalder et al. 2001; Shen et al. 2009 ), a significant extension of life span was observed when dAhcyL1 RNAi-1 was expressed starting at 1 wk in both males and females. A similar experiment with dAhcyL2 RNAi failed to reveal an effect (Fig.  4I,J) . In addition, the TIGS-2 GeneSwitch driver (TIGS-2), which is associated with digestive tract-specific expression (Poirier et al. 2008; Rera et al. 2011) , significantly extended life span when either dAhcyL1 RNAi-1 or dAhcyL2 RNAi-1 was expressed in adult females starting at 1 wk of age (Fig.  4K ,L)-a result consistent with the observation that downregulation of both dAhcyL1 and dAhcyL2 suppressed agedependent loss of intestine barrier function (Fig. 4E,F) . As expected, expression of control (w) RNAi did not affect life span with any organ-specific GeneSwitch driver (data not shown). Altogether, our results suggest that tissue-specific down-regulation of both dAhcyL1 and dAhcyL2 is sufficient to extend life span.
Noncanonical functions of dAHCY proteins are not involved in life span regulation
Canonical AHCY hydrolyzes SAH to adenosine and homocysteine. While adenosine is further deaminated to inosine, homocysteine is either remethylated to methionine or enters the transsulfuration pathway. Due to critical mutations in their AHCY domains, dAHCYL1 and dAHCYL2 proteins most likely have lost their canonical enzymatic functions. However, via heteromultimerization, ACHYL can suppress the enzymatic activity of AHCY and thus act as a dominant-negative regulator of canonical AHCY (Devogelaere et al. 2008 ). In addition, dAHCYL1 and dAHCYL2 proteins contain N-terminal IRBIT domains, and dAHCYL2 contains an N-terminal P/A domain enriched in Pro/Ala residues (Devogelaere et al. 2008) , which give dAHCYL1/dAHCYL2 proteins AHCY-independent/noncanonical functions. Thus, we tested whether these AHCY-independent functions are responsible for the effect on life span. AHCYL1 functions as an inhibitor of IP 3 R, which is a critical regulator of intracellular Ca 2+ signaling (Ando et al. 2006 ). Binding of IP 3 to IP 3 R causes the opening of the IP 3 R channel and Ca 2+ release, whereas AHCYL1 competes with IP 3 for IP 3 R binding but is unable to open the IP 3 R channel ( Fig.  5A ; Ando et al. 2006) . Life span was not affected by either down-regulation (Itp-r83A RNAi) (Fig. 5B) or up-regulation (UAS-Itp-r83A) (Fig. 5C ) of IP 3 R, suggesting that life span extension caused by down-regulation of dAHCYL1 is independent of IP 3 R. Note that the knockdown efficacy of the Itp-r83A RNAi line was tested using the ubiquitous Actin5c-Gal4 driver (Supplemental Fig. 3D ).
IRBIT domain-containing proteins form a deoxyadenosine triphosphate (dATP)-dependent complex with ribonucleotide reductase (RNR), stabilizing dATP in the active site of RNR and thus inhibiting the enzyme ( Fig.  5D ; Arnaoutov and Dasso 2014) . To test whether loss of dAHCYL1/dAHCYL2 activates RNR, we performed metabolomic profiling of flies expressing either dAhcyL1 RNAi-1 or control RNAi (against gfp) using the ubiquitous temperature-sensitive (tubulin-Gal4, tubulin-Gal80ts) driver for 7 d. No significant differences in dCDP, dTDP, dGDP, dTTP, and dGTP levels were observed between control and dAhcyL1 RNAi-1 flies (Fig. 5E,F,G) . Furthermore, as RNR is composed of two large (RnrL) and two small (RnrS) subunits that form an active tetramer (Fig.  5D) , activation of RNR would require coexpression of both subunits, and their overexpression would not necessarily increase RNR activity. To examine the role of RNR in life span regulation, we tested whether down-regulation of the large RNR subunit RnrL would affect life span. RnrL RNAi expression using the ActinGS system at 1 wk of age had no effect on life span in males (Fig.  5H) , suggesting that increased life span caused by dAHCYL1/dAHCYL2 down-regulation is unlikely linked to alteration in RNR activity. Note that the knockdown efficacy of the RnrL RNAi line was tested using Actin5c-Gal4 (Supplemental Fig. 3E ). Altogether, our data suggest that the putative noncanonical functions of dAHCYL1/dAHCYL2 are unlikely to be connected to their regulation of life span. dAhcyL1 and dAhcyL2 are involved in the regulation of methionine metabolism As dAHCYL1 and dAHCYL2 proteins have most likely lost their enzyme activities, we tested whether they can affect the activity of canonical Ahcy13 via heteromultimerization (Fig. 6A) . We confirmed the interaction between dAHCYL1 and Ahcy13 by coimmunoprecipitation in Drosophila S2R cells (Supplemental Fig. 5 ). To confirm the role of Ahcy13, we performed metabolomic profiling of flies that expressed either Ahcy13 RNAi-1 or control RNAi (against gfp) under the control of the ubiquitous temperature-sensitive (tubulin-Gal4, tubulin-Gal80ts) driver for 7 d. As expected, Ahcy13 down-regulation caused an ∼15-fold increase in SAH level (Fig. 6B) . The knockdown efficacy of Ahcy13 RNAi-1 and Ahcy13 RNAi-2 lines was tested using the ubiquitous Actin5c-Gal4 driver (Supplemental Fig. 3F) . Next, to test whether dAhcyL1 regulates SAH level, we performed metabolomic profiling of flies expressing dAhcyL1 RNAi-1. In contrast to Ahcy13, down-regulation of dAhcyL1 reduced SAH levels (Fig. 6C ) and homocysteine levels (Fig. 6D) , the product of SAH hydrolysis, suggesting that down-regulation of dAhcyL1 extends life span by promoting the activity of Ahcy13 and flux through the methionine cycle. To further test this hypothesis, we analyzed the effect of Ahcy13 downregulation on life span. RNAi against Ahcy13 using two different RNAi lines using ActinGS at 1 wk of age significantly suppressed life span in males (Ahcy13 RNAi-2, 11.9% decrease in median life span, P < 0.0001; and Ahcy13 RNAi-1, 7.5% decrease in median life span, P < 0.0001) (Fig. 6E,F) . In addition, as down-regulation of dAhcyL1 extends life span in a tissue-specific manner (Fig. 4I,K) , we tested whether Ahcy13 had the opposite effect on life span. Strikingly, Ahcy13 RNAi-1 expression in the nervous system significantly suppressed life span in males (10% median life span decrease, P < 0.0001) (Fig.  6G) . To further dissect which metabolites upstream of Ahcy13 are responsible for life span extension, we fed flies with either SAM or a methionine analog that acts as a specific inhibitor of Sam-S (Sufrin et al. 1979) . Addition of cycloleucine (Sam-S inhibition) phenocopied methionine depletion and resulted in life span extension (15.9% increase in median life span, P < 0.0001), while addition of SAM caused life span suppression (21% decrease in median life span with 500 µM SAM, P < 0.0001) (Fig. 6H,  I ). Because cycloleucine specifically reduces SAM and SAH levels but not methionine, it indicates that SAM and SAH, but not methionine, are essential for life span extension.
dAhcyL1 and dAhcyL2 are involved in the regulation of H3K4me3 levels and heterochromatin
The status of methionine metabolism is sufficient to determine H3K4me3 levels (but not H3K9me3 or H3K27me3) in human cells, and H3K4me3 peaks are associated with genes involved in methionine metabolism, establishing a circuit between methionine availability and expression of enzymes of methionine metabolism (Mentch et al. 2015) . Thus, we hypothesized that the down-regulation of dAhcyL1 would phenocopy methionine starvation and regulate H3K4me3 levels as well as the expression of enzymes involved in methionine metabolism. Strikingly, dAhcyL1 RNAi-1 from 7 to 40 d significantly suppressed the level of H3K4me3 but not total H3 levels (Fig. 7A) . Moreover, dAhcyL1 RNAi-1 from 7 to 40 d was associated with a decrease in the expression of three enzymes (ENOPH1, SMS, and MTAP) involved in methionine metabolism (Fig. 7B) . These changes suggest a feedback between dAhcyL1 down-regulation and the expression of enzymes involved in methionine metabolism (similar to methionine restriction in mammalian cells) (Mentch et al. 2015) .
Aging associated with loss of repressive heterochromatin marks can be measured using a position effect-variegated LacZ reporter gene (Jiang et al. 2013) , as the LacZ gene is positioned at the boundary between euchromatin and heterochromatin, and the level of heterochromatization determines the activity of LacZ expression. To test whether down-regulation of dAhcyL1 affects the level of heterochromatinization, we used ActinGS to express dAhcyL1 RNAi-1 in the presence of different LacZ reporters inserted in either euchromatic or heterochromatic regions. Interestingly, although down-regulation of dAhcyL1 suppressed H3K4me3 levels, down-regulation of dAhcyL1 did not affect the expression of the LacZ reporter inserted in the heterochromatin (data not shown).
DR extends the life span of many animals, including Drosophila (Tatar et al. 2014) . In mice, gene expression profiles of methionine-restricted and calorie-restricted mice do not significantly overlap, suggesting that these two dietary regimens may affect longevity through partly independent pathways (Sun et al. 2009 ). To test the possible interaction between DR and dAhcyL1 down-regulation in Drosophila, we expressed dAhcyL1 RNAi-1 using the inducible ActinGS and maintained flies with either a standard sugar/yeast diet (1× SY) or a diet in which amounts of sugar and yeast were reduced (0.5× SY). Both DR (28% median life span increase, P < 0.0001) and down-regulation of dAhcyL1 (dAhcyL1 RNAi-1, 13% median life span increase, P < 0.0001) significantly extended the life span, but no additional increase was observed when they were combined (Fig. 7C) , suggesting that they act through partially overlapping mechanisms. To test the possible interaction between high levels of methionine and dAhcyL1 down-regulation in Drosophila life span, we expressed dAhcyL1 RNAi-1 using the inducible ActinGS and maintained flies on a highmethionine diet (4.5 g/L). As expected, the life span of flies was significantly decreased (47% median life span decrease, P < 0.0001). However, down-regulation of dAhcyL1 (dAhcyL1 RNAi-1, 15% median life span increase, P < 0.0001) significantly extended the life span (Fig. 7D) . Overall, our results suggest that higher levels of methionine are not associated with decreased life span because naturally selected O1 and O3 longlived flies have higher levels of methionine compared with control B3 flies. Instead, accumulation of the methionine downstream product SAH is detrimental, with its levels being higher in old flies and lower in long-lived flies compared with control flies of the same age. Thus, our results suggest that enhancing flux downstream from SAH via the down-regulation of dAhcyL1 and dAhcyL2 decreases the level of SAH and extends life span (Fig. 7E) .
Discussion
By studying metabolic changes during fly aging, we identified two potential targets, CG9977/dAhcyL1 and Ahcy89E/CG8956/dAhcyL2, for health and life span extension. Whole-body and tissue-specific down-regulation of these two noncanonical, dominant-negative Drosophila homologs of Ahcy (AHCY is the rate-limiting enzyme in methionine metabolism that hydrolyzes SAH to adenosine and homocysteine) significantly extended life span, decreased levels of SAH, and suppressed H3K4me3. 
Age-dependent metabolic reprogramming
We searched for fly metabolome changes caused by aging and hypothesized that preventing some of these changes would increase life span and prevent agedependent health deterioration. Metabolite profiling revealed striking changes in the metabolome of aged flies, including altered levels of multiple methionine metabolism intermediates as well as several other previously known pathways affected by aging, including glutamate metabolism, glutathione metabolism, and the mitochondrial electron transport chain (Orr et al. 2005; Copeland et al. 2009 ).
Methionine restriction and life span extension
Restriction of a single amino acid, either methionine or tryptophan, extends life span in rodents (De Marte and Enesco 1986; Miller et al. 2005) . In addition, methionine restriction extends life span in yeast, flies, rodents, and human diploid fibroblasts (Orentreich et al. 1993; Koziel et al. 2014; Lee et al. 2014) . Methionine metabolism consists of three branches: salvage, de novo, and transsulfuration pathways. Methionine is converted into glutathione and taurine via the transsulfuration pathway supplying cells with antioxidant defense. In accordance, overexpression of CBS, the rate-limiting enzyme in the transsulfuration pathway, extends life span (Kabil et al. 2011) . Moreover, CBS is one of the primary sources of hydrogen sulfide production, which has been shown to function as an evolutionarily conserved mediator of DR-mediated longevity (Hine et al. 2015) . We identified two novel members of methionine metabolism (located upstream of the transsulfuration pathway) that can extend life span when down-regulated. Both dAhcyL1/CG9977 and dAhcyL2/Ahcy89E/CG8956 encode noncanonical AHCY/SAHH enzymes that most likely suppress the function of the canonical AHCY enzyme. A possible explanation for their effects on life span extension is that down-regulation of dAhcyL1 and dAhcyL2 would enhance flux into the transsulfuration pathway. However, we found that cycloleucine, an upstream inhibitor of Sam-S, also increases life span, suggesting that life span extension is most likely due to the clearance of metabolites between Sam-S and Ahcy13 (SAM and SAH).
Gnmt catalyzes the conversion of glycine to sarcosine using SAM as a donor of the methyl group, and recent studies have shown that Gnmt overexpression decreases levels of SAM and extends life span in flies (Obata and Miura 2015) . Although Gnmt overexpression extends life span, its product, sarcosine, was identified as a metabolite contributing to prostate cancer progression (Sreekumar et al. 2009) , and high cytoplasmic GNMT expression in patient tumor samples correlated with more aggressive forms of prostate cancer (Song et al. 2011) . Based on these data, dAhcyL1 and dAhcyL2 could represent better targets for developing methionine restriction mimetics, as they affect methionine indirectly via regulation of AHCY activity.
Canonical and noncanonical AHCY functions in life span regulation AHCY (Ahcy13 in flies) is a tetrameric enzyme that catalyzes the reversible hydrolysis of SAH to adenosine and L-homocysteine. SAH is formed as a by-product of SAM through methylation reactions, and hydrolysis of SAH is required to maintain proper concentrations of SAH, which serves as an inhibitor of SAM-dependent methylation reactions. Accordingly, inhibition of AHCY, which is associated with decreased life span, results in the intracellular accumulation of SAH (whole-body adult-onset Ahcy13 RNAi expression caused an ∼15-fold increase in whole-body SAH level). In contrast, down-regulation of dAhcyL1 moderately suppressed levels of SAH (approximately twofold decrease) and increased life span. Interestingly, the level of SAH was increased with age in OreR flies and was significantly lower in naturally selected long-lived flies compared with control flies at 7 wk of age. The mechanisms underlying the age-dependent changes of SAH and which of them affect the agedependent changes in Ahcy13 activity and methionine pathway activity are unknown. Possibly, age-dependent increased oxidative stress can redirect methionine flux into the transsulfuration pathway for glutathione production. It is also worth noting that alterations in SAH levels do not equally affect the activity of methyltransferases (Brosnan and Brosnan 2006) , an observation that warrants further investigation. dAHCYL1/dAHCYL2 proteins consist of a C-terminal AHCY domain and an N-terminal IRBIT domain (Devogelaere et al. 2008) . Due to the fact that dAHCYL1/ dAHCYL2 proteins likely have lost their enzyme activity, they can suppress Ahcy13 function via heteromultimerization. As the presence of an N-terminal IRBIT domain gives dAHCYL1/dAHCYL2 proteins new functions in Ca 2+ signaling, intracellular pH regulation, and production of deoxyribonucleotides (which are referred as noncanonical functions), we tested which downstream effectors of dAHCYL1/dAHCYL2 proteins are responsible for life span extension. Down-regulation of dAhcyL1 in the whole body did not affect the levels of deoxyribonucleotides, and the down-regulation of RnrL and Itp-r83A or overexpression of Itp-r83A had no effect on life span. Furthermore, dAhcyL1 down-regulation suppressed the levels of SAH and increased life span, contrary to Ahcy13 function. Altogether, these results suggest that down-regulation of dAhcyL1 promotes life span via modulating Ahcy13 function but not through noncanonical functions. The modular structure of AHCYL proteins suggests that they integrate different signals from Ca 2+ signaling, pH regulation, production of deoxyribonucleotides, SAH clearance, and life span regulation.
Maintenance of euchromatin/heterochromatin states
Several studies have shown that specific heterochromatin regions are remodeled during aging and that life spanextending interventions such as calorie restriction Suppression of SAH accumulation extends life span suppress age-dependent heterochromatin remodeling (Wood et al. 2010; Jiang et al. 2013 ). Moreover, heterochromatin formation prolongs life span, and its status depends on the levels of HP1 and H3K9me (Larson et al. 2012) . As the status of methionine metabolism is sufficient to determine the H3K4me3 (but not H3K9me3 or H3K27me3) levels in human cells (Mentch et al. 2015) , we hypothesized that down-regulation of dAhcyL1 and dAhcyL2 would mimic methionine starvation and affect H3K4me3 levels and the level of heterochromatinization. Accordingly, we found that down-regulation of dAhcyL1 suppressed H3K4me3 levels. In contrast, we did not observe any effect of down-regulation of dAhcyL1 on expression of a LacZ reporter gene located in the heterochromatin, which could be explained by differences in the effects of calorie restriction and methionine starvation.
Relevance to cancer, stem cells, and potential therapeutic applications Interestingly, the mammalian homolog of Ahcy13 (SAHH) was recovered in a loss-of-function genetic screen as a putative tumor suppressor gene, and its mRNA was lost in 50% of tumor tissues studied in comparison with normal tissue (Leal et al. 2008) . Moreover, elevated homocysteine levels have been reported as a risk factor for dementia and Alzheimer's disease (Seshadri et al. 2002) . As we have proposed that down-regulation of dAhcyL1 and dAhcyL2 activates Ahcy13 (SAHH), it will be important to examine whether dAhcyL1/2 can affect carcinogenesis. In addition, methionine metabolism and SAM levels have been shown to be critical for the maintenance and differentiation of human embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) (Shiraki et al. 2014) . Interestingly, wild-type flies exhibit age-dependent intestine stem cell (ISC) hyperproliferation and misdifferentiation, causing loss of intestinal integrity, whereas genetic manipulations that improve proliferative homeostasis extend life span (Biteau et al. 2010) . Our data suggest that down-regulation of dAhcyL1 and dAhcyL2 suppresses age-dependent SAH accumulation and prevents loss of intestinal integrity (as revealed by the "Smurf" assay) and that their ubiquitous and tissue-specific down-regulation extends life span. The precise mechanisms of ISC regulation by methionine metabolism and SAH are interesting subjects for further studies.
Materials and methods
Life span analysis
For survival analysis, flies were collected within 24 h of eclosion, sorted by sex under light CO 2 anesthesia, and reared at a standard density (20-25 flies per vial) on cornmeal/soy flour/yeast fly food at 25°C and 60% humidity with a 12-h on/off light cycle. Flies were transferred to fresh vials every 2 d, and dead flies were counted. RU486 dissolved in ethanol was administered in the medium at the final concentration of 150 µg/mL. dAhcyL1 corresponds to CG9977, and dAhcyL2 corresponds to CG8956/Ahcy89E. The following RNAi lines were used: dAhcyL1 RNAi-1 (HM05009), dAhcyL1 RNAi-2 (HMC04803), dAhcyL2 RNAi-1 (HMJ23469), dAhcyL2 RNAi-2 (8956R-1), Rheb RNAi (HMS00923), w RNAi (HMS00017), Itp-r83A RNAi (HMC03351), gfp RNAi (HMS00314), RnrL RNAi (HMC02351), and Ahcy13 RNAi-1 (HMC03222).
Statistical analysis
Statistical analyses were performed in either JMP (SAS) or Excel.
Metabolite profiling
Twenty flies per sample (five biological replicates) were collected, and intracellular metabolites were extracted using 80% (v/v) aqueous methanol. A 5500 QTRAP hybrid triple quadrupole mass spectrometer (AB/SCIEX) coupled to a Prominence UFLC high-performance LC (HPLC) system (Shimadzu) was used for steady-state analyses of the samples. Selected reaction monitoring (SRM) of 287 polar metabolites using positive/negative switching with hydrophilic interaction LC (HILIC) was performed. Peak areas from the total ion current for each metabolite SRM transition were integrated using MultiQuant version 2.1 software (AB/SCIEX). The resulting raw data from the MultiQuant software were analyzed using MetaboAnalyst (http://www. metaboanalyst.ca/MetaboAnalyst).
An extended Material and Methods section is in the Supplemental Material.
